Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

ANTIMICROBIAL SUSCEPTIBILITY OF PROTEUS MIRABILIS STRAINS ISOLATED FROM URINARY TRACT INFECTIONS

Show simple item record

dc.contributor.author Boescu, Ion
dc.date.accessioned 2026-10-30T12:50:28Z
dc.date.accessioned 2026-11-17T11:36:49Z
dc.date.available 2026-10-30T12:50:28Z
dc.date.available 2026-11-17T11:36:49Z
dc.date.issued 2026
dc.identifier.citation Boescu, Ion. ANTIMICROBIAL SUSCEPTIBILITY OF PROTEUS MIRABILIS STRAINS ISOLATED FROM URINARY TRACT INFECTIONS. In: MedEspera 2026, p. 28. ISBN 978-9975-82-486-6. en_US
dc.identifier.isbn 978-9975-82-486-6
dc.identifier.uri https://medespera.md/documents/abstract-book-4.pdf
dc.identifier.uri https://repository.usmf.md/handle/20.500.12710/33848
dc.description Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu”, Chișinău, Republica Moldova en_US
dc.description.abstract Introduction. Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting both community and hospital populations. Most cases are caused by Gram-negative bacteria belonging to the Enterobacteriaceae family. Among them, Proteus mirabilis is an important opportunistic pathogen frequently associated with complicated and catheter-associated UTIs. Its pathogenicity is related to several virulence factors, including urease production, swarming motility, and biofilm formation, which facilitate urinary tract colonization and promote urinary stone formation. The increasing antimicrobial resistance of P. mirabilis strains represents a significant public health concern and highlights the need for continuous monitoring of antimicrobial susceptibility patterns. Aim of study. To evaluate the antimicrobial susceptibility profile of Proteus mirabilis strains isolated from urine samples and to identify the main resistance patterns associated with urinary tract infections. Methods and materials. Proteus mirabilis strains were isolated from urine samples collected from patients with clinical suspicion of urinary tract infection. Identification was performed using standard microbiological culture methods and biochemical tests. Antimicrobial susceptibility testing was carried out using the Kirby-Bauer disk diffusion method on Mueller-Hinton agar, according to international standards established by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Analysis and interpretation of antimicrobial resistance patterns were supported by current scientific literature and clinical guidelines from PubMed/MEDLINE, WHO reports, and European Association of Urology (EAU) guidelines. Results. The analysis demonstrated variability in antimicrobial susceptibility among the isolated Proteus mirabilis strains. Increased resistance was observed to ampicillin, trimethoprim-sulfamethoxazole, and early-generation cephalosporins, which are commonly used in empirical UTI therapy. Higher susceptibility was recorded for aminoglycosides, fluoroquinolones, and beta-lactam/beta-lactamase inhibitor combinations. A proportion of isolates exhibited multidrug-resistant phenotypes, indicating a growing trend of antimicrobial resistance among uropathogenic bacteria. Conclusions. Proteus mirabilis from urinary tract infections show variable antibiotic susceptibility, with increasing resistance. Ongoing monitoring and rational antibiotic use are essential to guide therapy and limit multidrug resistance. en_US
dc.publisher Centrul Editorial-Poligrafic Medicina en_US
dc.relation.ispartof MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026 en_US
dc.subject Proteus mirabilis en_US
dc.subject antimicrobial susceptibility en_US
dc.subject urinary tract infection en_US
dc.subject antimicrobial resistance en_US
dc.subject uropathogens en_US
dc.title ANTIMICROBIAL SUSCEPTIBILITY OF PROTEUS MIRABILIS STRAINS ISOLATED FROM URINARY TRACT INFECTIONS en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2026
    The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026

Show simple item record

Search DSpace


Advanced Search

Browse

My Account